Targeting <i>mir128-3p</i> alleviates myocardial insulin resistance and prevents ischemia-induced heart failure.
Ontology highlight
ABSTRACT: Myocardial insulin resistance contributes to heart failure in response to pathological stresses, therefore, a therapeutic strategy to maintain cardiac insulin pathways requires further investigation. We demonstrated that insulin receptor substrate 1 (IRS1) was reduced in failing mouse hearts post-myocardial infarction (MI) and failing human hearts. The mice manifesting severe cardiac dysfunction post-MI displayed elevated mir128-3p in the myocardium. Ischemia-upregulated mir128-3p promoted Irs1 degradation. Using rat cardiomyocytes and human-induced pluripotent stem cell-derived cardiomyocytes, we elucidated that mitogen-activated protein kinase 7 (MAPK7, also known as ERK5)-mediated CCAAT/enhancer-binding protein beta (CEBPβ) transcriptionally represses mir128-3p</
SUBMITTER: Ruiz-Velasco A
PROVIDER: S-EPMC7124275 | biostudies-literature | 2020 Mar
REPOSITORIES: biostudies-literature
ACCESS DATA